Pendulum GLP-1 Probiotic is formulated by a team of PhD scientists from Johns Hopkins, Harvard, Berkeley and Stanford backed by Mayo Clinic, Sequoia Capital and over $111 million in research investment combining Akkermansia muciniphila with complementary probiotic strains specifically selected to support gut barrier integrity, microbiome diversity and the gut signalling environment associated with appetite and craving management
Improved insulin sensitivity and glucose control are powerful health victories
Consult a healthcare provider if pregnant, breastfeeding, or taking medication
Be skeptical of specific numbers (e.g., a particular half-life in hours, or a specific oral bioavailability percentage) circulating on commercial or community sites these could not be located in peer-reviewed literature and directly conflict with the peer-reviewed consensus that no human trials of this compound have been conducted
Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life
